Geier Asset Management, Inc. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 53 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geier Asset Management, Inc. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2021$55,000
-23.6%
35,0000.0%0.04%
-28.3%
Q1 2021$72,000
-20.9%
35,0000.0%0.05%
-28.4%
Q4 2020$91,00035,0000.07%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2021
NameSharesValueWeighting ↓
MARATHON CAPITAL MANAGEMENT 55,000$179,0000.09%
WEDBUSH SECURITIES INC 180,945$590,0000.09%
Brown Advisory Securities, LLC 28,000$91,0000.03%
FNY Managed Accounts LLC 8,000$26,080,0000.02%
FT Options LLC 10,000$26,0000.02%
WEBSTER BANK, N. A. 40,000$130,0000.02%
GSA CAPITAL PARTNERS LLP 30,907$101,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$82,0000.00%
NATIONAL PLANNING CORP 11,000$32,0000.00%
Virtu KCG Holdings LLC 24,705$81,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders